Epitalon (Epithalon)

What Is Epithalon?

Epithalon (also Epitalon, Epithalone; synthetic analog of the pineal extract Epithalamin) is a short tetrapeptide widely used in experimental gerontology and neuroendocrine research.

Key research themes include:

• Telomerase modulation and telomere maintenance
• Melatonin regulation and circadian rhythm support
• Epigenetic and chromatin remodeling
• Tumor biology, immune aging, and microvascular function

Epithalon was originally developed in Russia in the 1980s. Most data derive from:

• In vitro cell and tissue studies
• Rodent models of aging, circadian disruption, and tumorigenesis
• Limited human studies conducted mainly in Russian gerontological centers

It is not approved for the treatment, mitigation, or prevention of any disease.

Epithalon Structure & Identity

• Sequence: Ala–Glu–Asp–Gly (AEDG)
• Peptide type: Synthetic tetrapeptide
• Molecular formula: C₁₄H₂₂N₄O₉
• Approx. molecular weight: 390.35 g/mol
• Synonyms: Epithalon, Epitalon, Epithalone; synthetic analog of Epithalamin

Telomerase, Telomeres, and Cellular Aging

Normal somatic cells possess a finite proliferative capacity (the Hayflick limit), largely driven by progressive telomere shortening:

• Telomeres are protective nucleoprotein caps at chromosome ends.
• With each division, telomeres shorten until a critical length is reached.
• Cells then undergo senescence, stop dividing, and can contribute to tissue aging.

The telomerase enzyme can partially restore telomeric DNA, extending the replicative lifespan of some cells in vitro.

Research with Epithalon suggests:

• Upregulation of telomerase expression and activity in certain human cell lines
• Delayed onset of senescence and extended replicative capacity under controlled culture conditions

These properties make Epithalon a useful tool compound in telomere and cellular aging research, while long‑term systemic effects in vivo remain incompletely defined.

Epithalon, DNA Regulation, and Chromatin

Experimental work, largely from Russian gerontology groups, indicates that Epithalon may:

• Modify chromatin structure, increasing accessibility of specific genomic regions
• Re‑activate genes that became transcriptionally silent with age
• Influence genes involved in:
• Immune system maintenance
• Development and differentiation
• General cellular repair and homeostasis

In older human subjects (ages 60–74) receiving courses of pineal peptide complexes containing or analogous to Epithalon over 2–3 years:

• Reported physiological benefits persisted for up to 3 years after cessation.
• Authors proposed durable epigenetic and chromatin-level changes as a possible mechanism.

These interpretations are preliminary and require rigorous, independent validation.

Experimental Mechanisms & Signaling Pathways

Across in vitro and animal models, Epithalon has been associated with:

• Telomerase activation – extended replicative lifespan in certain cell types
• MAPK/ERK pathway modulation – potential effects on proliferation, inflammation, and stress responses
• Circadian-associated transcriptional regulation – consistent with its impact on melatonin secretion and clock gene expression

Various specific designations sometimes listed for Epithalon’s DNA actions (e.g., CER, ER2, Twist1, ZCREB1) are best considered hypothesis-level or context‑specific and not yet universally established targets.

Tumor Growth and Immune Function (Preclinical)

In oncology research, Epithalon and pineal peptide preparations have been evaluated mainly in aged rodent models:

• Long-term administration of pineal peptide complexes containing Epithalon has been reported to:
• Reduce spontaneous tumor incidence, including pineal and colon tumors
• Achieve roughly 2.6–2.8‑fold reductions in some tumor types
• Decrease overall tumor occurrence by approximately 40% under certain protocols

Additional data from cell and small clinical studies suggest:

• Altered gene expression profiles linked to tumor suppression and immune modulation
• In immunocompromised individuals, periodic courses of pineal peptides were associated with enhanced resistance to illness and improved survival indices

However:

• Most results originate from a single, geographically concentrated research network.
• Telomerase activation can be pro‑ or anti‑tumorigenic depending on context.

Accordingly, Epithalon remains an experimental reagent, not an approved anticancer or immunomodulatory therapy.

Melatonin Secretion and Circadian Rhythms

Aging is accompanied by:

• Declining pineal gland output
• Reduced nighttime melatonin levels
• Disrupted circadian rhythms, which are associated with:
• Metabolic disturbances
• Immune impairment
• Elevated risk of certain malignancies

In rodent models, pineal extracts containing Epithalon (e.g., PESI – pineal extract of substance inhibiting aging) and synthetic Epithalon have been shown to:

• Restore or enhance melatonin secretion after age-related decline
• Improve circadian rhythm regularity
• Extend lifespan in specific experimental conditions

These data support the concept that circadian and neuroendocrine normalization may be a key component of Epithalon’s reported geroprotective effects in preclinical studies.

Microcirculation and Ocular Research

Age-related visual decline often reflects:

• Reduced retinal and choroidal blood flow
• Microvascular degeneration
• Enhanced susceptibility to degenerative ocular conditions

Experiments with Epithalon and pineal peptides in aging animals have reported:

• Improved retinal microcirculation
• Partial correction of an estimated ~40% age-related reduction in ocular blood flow

Such microvascular changes may:

• Improve nutrient and oxygen delivery to retinal tissue
• Enhance waste product clearance
• Provide a basis for exploring Epithalon’s role in ocular and vascular aging models

These findings remain exploratory and preclinical.

Principal Investigator: Prof. Vladlen Khavinson

A large portion of the Epithalon literature stems from the work of Prof. Vladlen Khavinson, a leading figure in peptide bioregulation:

• President, European Region of the International Association of Gerontology and Geriatrics (IAGG)
• Director, Saint Petersburg Institute of Bioregulation and Gerontology, Russia
• Author/co‑author of extensive work on:
• Short peptide regulation of gene expression
• Peptide applications in gerontology and oncology
• Transition from basic peptide science to early clinical use

While influential, this body of work still requires broad independent replication and integration into international standards before any clinical extrapolation.

Article Author

This product description and literature synthesis were researched and prepared by Dr. Logan, M.D.

• M.D. – Case Western Reserve University School of Medicine
• Additional certification in molecular biology

Selected References

1. Khavinson VK, Anisimov VN, Zabezhinskii MI, et al. Effect of the pineal peptide preparation epithalamin on the life span and pineal and serum melatonin level in old rats. Ann N Y Acad Sci. 1994;719:393–407.
2. Khavinson VK, Chalisova GM, Ashapkin N, Shataeva N, Cartwright A. Mechanisms underlying the immunomodulatory actions of pineal peptides and their use in cancer control strategy. Biol Today. 2012;8:13–20.
3. Khavinson VK, Morozov VG, Abisheva IA, Semenchenko SI, Vanyushin SV. Effect of pineal peptide preparation epithalamin on the proliferation and the development of spontaneous tumors in old rodents. Front Aging Neurosci. 2013;5:128.
4. Khavinson VK, Malinin AV. Gerontological aspects of genome peptide regulation: the role of short peptides. Biogerontology. 2005;6(3):191–201.
5. Khavinson VK, Aliakina IV, Ryzhak GA, Muradian N, Anisimov V, Suchkov RA. Effect of epithalamin on the life span and hypothalamus resistance to aging. Adv Gerontol. 2005;8(2):109–114.
6. Dave S, Kavanagh R, Sheridan J, et al. The association between body mass index and tumor size in soft tissue sarcomas and GIST-soft tumors. Medicine (Baltimore). 2016;95(34):e4578.
7. Khavinson VK, Shataeva LK, Chalisova KA. Effect of regulatory peptides on DNA synthesis in irradiated and non-irradiated splenocytes. Bull Exp Biol Med. 1995;119(1):79–81.
8. Kubanova DV, et al. Deconvolution effect of the pineal-gland peptide on the fatty acid cholesterol esters in the choroidal and ciliary body in albino rats and their correlation with degenerative processes. Tsitologiia. 2008;50(9):779–782.
9. Khavinson V, Goncharova B, Lapin N. Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescence accelerated OXYS rats. Neuroendocrinol Lett. 2001;22(4):251–254.
10. Chalisova NI, Litivina ME, Shchukin MM, Drozdov AG, Ryzhak GA, Khavinson VK. Effect of peptide epitalon on microvascular reactions and their role in age-dependent reorganization of tissues. Bull Exp Biol Med. 2006;141(4):452–455.
11. Linke NV, Pankova AA. Peptide regulation of skin fibroblast functions during aging in vitro. Bull Exp Biol Med. 2009;148(1):151–155.
12. Vinogradova IV, Ruslova VV, Zabezhinskii MV, et al. The geroprotective property of epithalon and metformin during aging. Adv Gerontol. 2017;30(1):93–104.